These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39037946)

  • 1. Challenges and Opportunities with Antibiotic Discovery and Exploratory Research.
    Piddock LJV; Malpani R; Hennessy A
    ACS Infect Dis; 2024 Aug; 10(8):2445-2447. PubMed ID: 39037946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development.
    Balasegaram M; Piddock LJV
    ACS Infect Dis; 2020 Jun; 6(6):1295-1298. PubMed ID: 32406675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic discovery in the artificial intelligence era.
    Lluka T; Stokes JM
    Ann N Y Acad Sci; 2023 Jan; 1519(1):74-93. PubMed ID: 36447334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance crisis: could artificial intelligence be the solution?
    Liu GY; Yu D; Fan MM; Zhang X; Jin ZY; Tang C; Liu XF
    Mil Med Res; 2024 Jan; 11(1):7. PubMed ID: 38254241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Together towards a common goal: REVIVE, a community of antimicrobial researchers brought together by the Global Antibiotic Research & Development Partnership (GARDP).
    Pentz-Murr A; Piddock LJV
    J Antimicrob Chemother; 2019 Jul; 74(7):1769-1770. PubMed ID: 30793751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Global Antibiotic Research and Development Partnership (GARDP): a not-for-profit antibiotic development organisation.
    Piddock LJ;
    Lancet Infect Dis; 2018 Dec; 18(12):1304-1305. PubMed ID: 30420229
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges and shortcomings of antibacterial discovery projects.
    Theuretzbacher U; Baraldi E; Ciabuschi F; Callegari S
    Clin Microbiol Infect; 2023 May; 29(5):610-615. PubMed ID: 36503116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic discovery with artificial intelligence for the treatment of
    Boulaamane Y; Molina Panadero I; Hmadcha A; Atalaya Rey C; Baammi S; El Allali A; Maurady A; Smani Y
    mSystems; 2024 Jun; 9(6):e0032524. PubMed ID: 38700330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating antibiotic discovery through artificial intelligence.
    Melo MCR; Maasch JRMA; de la Fuente-Nunez C
    Commun Biol; 2021 Sep; 4(1):1050. PubMed ID: 34504303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Antibiotic R&D Calling for a Global Strategy Considering Both Short- and Long-Term Solutions.
    Kållberg C; Salvesen Blix H; Laxminarayan R
    ACS Infect Dis; 2019 Aug; 5(8):1265-1268. PubMed ID: 31144803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.
    Simpkin VL; Renwick MJ; Kelly R; Mossialos E
    J Antibiot (Tokyo); 2017 Dec; 70(12):1087-1096. PubMed ID: 29089600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence as a smart approach to develop antimicrobial drug molecules: A paradigm to combat drug-resistant infections.
    Talat A; Khan AU
    Drug Discov Today; 2023 Apr; 28(4):103491. PubMed ID: 36646245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational biology: Role and scope in taming antimicrobial resistance.
    Sharma P; Dahiya S; Kaur P; Kapil A
    Indian J Med Microbiol; 2023; 41():33-38. PubMed ID: 36870746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.
    Ting DSJ; Beuerman RW; Dua HS; Lakshminarayanan R; Mohammed I
    Front Immunol; 2020; 11():983. PubMed ID: 32528474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial drug discovery in the resistance era.
    Brown ED; Wright GD
    Nature; 2016 Jan; 529(7586):336-43. PubMed ID: 26791724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems-Level Chemical Biology to Accelerate Antibiotic Drug Discovery.
    Farha MA; French S; Brown ED
    Acc Chem Res; 2021 Apr; 54(8):1909-1920. PubMed ID: 33787225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public funding of clinical-stage antibiotic development in the United States and European Union.
    Eichberg MJ
    Health Secur; 2015; 13(3):156-65. PubMed ID: 26042859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global preclinical antibacterial pipeline.
    Theuretzbacher U; Outterson K; Engel A; Karlén A
    Nat Rev Microbiol; 2020 May; 18(5):275-285. PubMed ID: 31745331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of antibacterial discovery.
    Silver LL
    Clin Microbiol Rev; 2011 Jan; 24(1):71-109. PubMed ID: 21233508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.